However, the specific mechanism about how FOXO1 regulates the RhoA/ROCK-2 signaling pathway, animal experiments, and clinical trials needs to be further investigated to provide more theoretical basis for the realization of miR-31-3p as an in vitro clinical diagnosis of NSCLC. This evidence concerns the gene RHOA and non-small cell lung carcinoma.